Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023
The top 20 biopharmaceutical companies saw prominent shifts in market capitalisation over 2023 despite various obstacles.
The top 20 biopharmaceutical companies saw prominent shifts in market capitalisation over 2023 despite various obstacles.
What's Your Reaction?
